Clinical Trial

Post-Market Evaluation of Active Thrombectomy and Proximal Aspiration During Lower Extremity Tibial Interventions

Study acronym: Protexus 1
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 16, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
Post-Market Evaluation of Active Thrombectomy and Proximal Aspiration during Lower Extremity Tibial Interventions
Trial Details
NCT Number NCT06929832
Lead Sponsor Protexa Endovascular, Inc.
Conditions Peripheral Arterial Disease
Enrollment 20 participants
Start Date 2025-04
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-04-16